364 results
Pharmacologic treatment algorithms by Global Initiative for Chronic Obstructive Lung Disease grade. Highlighted boxes and arrows
patients with a major discrepancy ... LAMA: long-acting ... muscarinic antagonist; LABA ... COPD #GOLD2017 #LAMA ... #LABA #ICS #Guidelines
Chart of Inhalers for Asthma and COPD
 - SABA - Short Acting Beta-2 Agonists
 - SAMA
-2 Agonists - SAMA ... Antagonists - SAMA ... -2 Agonists - LAMA ... Antagonists - LAMA ... - ICS + LAMA +
Medical Treatment Algorithm for Chronic Obstructive Pulmonary Disease
Initial medical treatment of chronic obstructive pulmonary disease (COPD)
corticosteroid; LABA ... long-acting β2-agonist; LAMA ... short-acting β2-agonist; SAMA ... Management #Pulmonary #LABA ... #LAMA #SABA #SAMA
Long-Acting Dual Bronchodilators - LAMA/LABA Combo Inhalers 

The FDA approved a new dual bronchodilator (LABA/LAMA) combination
Bronchodilators - LAMA ... /LABA Combo Inhalers ... bronchodilator (LABA ... /LAMA) combination ... Bronchodilators #LAMA
Asthma Maintenance Therapy - Stepwise Approach 

Low dose ICS 
-> Low dose ICS/LABA or Med/High dose
> Low dose ICS/LABA ... > Med dose ICS/LABA ... High dose ICS/LABA ... , tiotropium (LAMA ... Respimat is the only LAMA
COPD Preferred Treatments - GOLD 2018 

COPD is a common progressive respiratory condition that can be
beta2 agonist) LAMA ... of therapy is LAMA ... bronchodilators of LAMA ... /LABA, and lastly ... LAMA/LABA/ICS.
First-line therapies for Asthma, Asthma-COPD Overlap and COPD

The diagnosis of COPD, asthma, and ACO initially requires
corticosteroids; LABA ... long-acting β2-agonist; LAMA
Daliresp (Roflumilast) 
Indication: Reduce risk of COPD exacerbations 
Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor 
GOLD 2019
Triple Therapy (LAMA ... /LABA/ICS) - ... Bronchodilators (LAMA ... /LABA) & Eosinophils
Causes of Growth Discrepancy: Large for Gestational Age - Differential Diagnosis Algorithm
Maternal Factors:
 • Multiparity
 •
Causes of Growth Discrepancy
Diabetic Foot Guidelines: Test patients w diabetes for peripheral neuropathy using the Semmes-Weinstein test
JAMA. 2017;318(14):1387-1388. doi:10.1001/jama.2017.11700

#Diagnosis
Semmes-Weinstein test JAMA ... 1388. doi:10.1001/jama